Glomerulonephritis clinical trials at UCSD

1 in progress, 0 open to eligible people

Sibeprenlimab in the Treatment of A Nephropathy (IgAN)
Sorry, in progress, not accepting new patients
To Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Subjects with Primary Immunoglobulin A Nephropathy
La Jolla, California and other locations

Last updated: February 18, 2026